Nuwellis
expanding use of ultrafiltration across hospital specialty units improves outcomes for fluid overloaded patients cardiac surgery liver transplants sepsis adult | Nuwellis
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
10 of 26
Similar slides by Nuwellis
See diffirences between slides (animation)
Investor Presentation
August 2023
expanding use of ultrafiltration across hospital specialty units improves outcomes for fluid overloaded patients surgery transplants mid to long term sane psis advanced liver disease adult | Nuwellis
Related slides by other companies
Mednow
Investor Presentation
July 2022
strategic acquisition of canada and liver specialty group group | Mednow
Ashtead Group
Results
March 2022
specialty market sizing rental penetration share revenue will grow by in with ample opportunity beyond group | Ashtead Group
AstraZeneca
Results
November 2023
accelerating presence in obesity with a novel once daily oral potential for no titration high tolerability profile novel once daily oral small molecule efficacy at low doses to significant market opportunity in obesity people living with obesity obesity is driver for chronic diseases opportunity beyond obesity to address disease phase planned strong track record in renal metabolic diseases opportunity for and combinations to address broad range of morbid diseases excuse | AstraZeneca
Aeglea BioTherapeutics
Investor Presentation
April 2023
| Aeglea BioTherapeutics
Other recent decks by Nuwellis
See all presentations (2 decks)
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights